265 related articles for article (PubMed ID: 2207109)
1. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
Longstaff C; Campbell AF; Fersht AR
Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
[TBL] [Abstract][Full Text] [Related]
2. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
[TBL] [Abstract][Full Text] [Related]
3. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
Kojima S; Nishiyama Y; Kumagai I; Miura K
J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
[TBL] [Abstract][Full Text] [Related]
5. A study of the specificity of barley chymotrypsin inhibitor 2 by cysteine engineering of the P1 residue.
Hasan Z; Leatherbarrow RJ
Biochim Biophys Acta; 1998 May; 1384(2):325-34. PubMed ID: 9659394
[TBL] [Abstract][Full Text] [Related]
6. Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b.
Greagg MA; Brauer AB; Leatherbarrow RJ
Biochim Biophys Acta; 1994 Jun; 1222(2):179-86. PubMed ID: 8031854
[TBL] [Abstract][Full Text] [Related]
7. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
[TBL] [Abstract][Full Text] [Related]
8. A novel double-headed proteinaceous inhibitor for metalloproteinase and serine proteinase.
Hiraga K; Suzuki T; Oda K
J Biol Chem; 2000 Aug; 275(33):25173-9. PubMed ID: 10827083
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action.
Kojima S; Deguchi M; Miura K
J Mol Biol; 1999 Feb; 286(3):775-85. PubMed ID: 10024450
[TBL] [Abstract][Full Text] [Related]
10. Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity.
Jackson SE; Fersht AR
Biochemistry; 1994 Nov; 33(46):13880-7. PubMed ID: 7947796
[TBL] [Abstract][Full Text] [Related]
11. Design of a small peptide-based proteinase inhibitor by modeling the active-site region of barley chymotrypsin inhibitor 2.
Leatherbarrow RJ; Salacinski HJ
Biochemistry; 1991 Nov; 30(44):10717-21. PubMed ID: 1931991
[TBL] [Abstract][Full Text] [Related]
12. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
Kojima S; Minagawa T; Miura K
FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
[TBL] [Abstract][Full Text] [Related]
13. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
[TBL] [Abstract][Full Text] [Related]
14. Primary structure and inhibitory properties of a subtilisin-chymotrypsin inhibitor from Streptomyces virginiae.
Terabe M; Kojima S; Taguchi S; Momose H; Miura K
Eur J Biochem; 1994 Dec; 226(2):627-32. PubMed ID: 8001578
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
[TBL] [Abstract][Full Text] [Related]
16. Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues.
Masuda-Momma K; Hatanaka T; Inouye K; Kanaori K; Tamura A; Akasaka K; Kojima S; Kumagai I; Miura K; Tonomura B
J Biochem; 1993 Oct; 114(4):553-9. PubMed ID: 8276767
[TBL] [Abstract][Full Text] [Related]
17. Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2.
Radisky ES; Lu CJ; Kwan G; Koshland DE
Biochemistry; 2005 May; 44(18):6823-30. PubMed ID: 15865427
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding. Refolding and inhibitory abilities of propeptide mutants.
Li Y; Hu Z; Jordan F; Inouye M
J Biol Chem; 1995 Oct; 270(42):25127-32. PubMed ID: 7559646
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
Braxton S; Wells JA
Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
[TBL] [Abstract][Full Text] [Related]
20. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
Brömme D; Fittkau S
Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
